dipyridamole has been researched along with Adjuvant Arthritis in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to evaluate the effects of dipyridamole alone and in combination with either the nitric oxide donor, sodium nitroprusside (SNP) or the non-selective nitric oxide synthase inhibitor, L-NG- monomethyl arginine (L-NMMA), on pathogenesis of adjuvant-induced arthritis model in rats." | 5.36 | Influence of dipyridamole and its combination with NO donor or NO synthase inhibitor on adjuvant arthritis. ( Afifi, N; Elshenawy, M; Gomaa, A; Mohammed, E; Thabit, R, 2010) |
| " The aim of this study was to evaluate the effects of dipyridamole alone and in combination with either the nitric oxide donor, sodium nitroprusside (SNP) or the non-selective nitric oxide synthase inhibitor, L-NG- monomethyl arginine (L-NMMA), on pathogenesis of adjuvant-induced arthritis model in rats." | 1.36 | Influence of dipyridamole and its combination with NO donor or NO synthase inhibitor on adjuvant arthritis. ( Afifi, N; Elshenawy, M; Gomaa, A; Mohammed, E; Thabit, R, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomaa, A | 1 |
| Elshenawy, M | 1 |
| Afifi, N | 1 |
| Mohammed, E | 1 |
| Thabit, R | 1 |
1 other study available for dipyridamole and Adjuvant Arthritis
| Article | Year |
|---|---|
Influence of dipyridamole and its combination with NO donor or NO synthase inhibitor on adjuvant arthritis.
Topics: Animals; Arthritis, Experimental; Dipyridamole; Drug Therapy, Combination; Enzyme Inhibitors; Female | 2010 |